A Dramatically Changing Landscape In Acute Myeloid Leukemia
Precision Oncology Making Inroads
Market Snapshot: Acute myeloid leukemia is a serious condition that affects people mainly in late middle age, for which there is a large R&D pipeline of candidate products being researched by pharmaceutical and biotech companies, many of whom are using a targeted medicine approach.